tirzepatide pancreatitis The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity Tirzepatide and Pancreatitis Risk: Safety
Description
- Creatinine
Ghashghaei N et al
“Semaglutide, a glucagon-like peptide-1 receptor agonist, was approved by the FDA for type 2 diabetes mellitus in 2017 and for
Weight loss is great for your health, but GLP-1s can sometimes leave the face looking hollow
Purpose of Review Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are used by increasing numbers of patients, but may adversely affect the safety of endoscopic procedures, due to their association with decreased gastrointestinal motility
HIGHLIGHTS: Grab-and-go stick packs
